FDA panel endorses kid-size doses

FDA panel meets Tuesday to discuss COVID-19 vaccine for children

The Food and Drug Administration is considering kid-sized doses of the Pfizer vaccine for elementary school-aged children — and if regulators give the OK, shots could begin early next month.